Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Amplia Therapeutics Limited, explained in plain language.
This study tests a new daily pill (narmafotinib) combined with standard chemotherapy (FOLFIRINOX) in about 67 people with pancreatic cancer that has spread. The goal is to find the safest and most effective dose. This is not a cure, but aims to better control the disease.
Phase: PHASE1, PHASE2 • Sponsor: Amplia Therapeutics Limited • Aim: Disease control
Last updated May 26, 2026 12:01 UTC